DARA Biosciences, Inc. Competitors

DARA 
$0.7997
*  
0.0098
1.21%
Get DARA Alerts
*Delayed - data as of Nov. 24, 2014  -  Find a broker to begin trading DARA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    DARA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Competitor Industry: Major Pharmaceuticals

DARA Biosciences, Inc.
CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Puma Biotechnology Inc
PBYI: NYSE
$ 231.97 7.89 ▲ 236,391 $ 233.94
$ 223.23
$ 279.37
$ 43.63
NE 6,993,431,560
Receptos, Inc.
RCPT: NASDAQ-GS
$ 126.67 7.48 ▲ 1,208,230 $ 130.785
$ 120.60
$ 121.8799
$ 22.02
NE 3,455,430,930
Prosensa Holding N.V.
RNA: NASDAQ-GS
$ 18.60 7.16 ▲ 5,534,474 $ 18.99
$ 18.34
$ 13.7499
$ 3.95
NE 668,353,800
Actavis, Inc.
ACT: NYSE
$ 266.88 7.13 ▲ 4,185,398 $ 268.34
$ 261.06
$ 270.34
$ 156.40
NE 70,739,479,680
Five Prime Therapeutics, Inc.
FPRX: NASDAQ-GS
$ 20.70 4.95 ▲ 704,288 $ 20.76
$ 16.51
$ 23.33
$ 8.63
NE 445,484,700
PTC Therapeutics, Inc.
PTCT: NASDAQ-GS
$ 44.41 4.64 ▲ 633,685 $ 44.66
$ 39.92
$ 47.20
$ 14.33
NE 1,470,104,230
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 409.75 4.50 ▲ 651,646 $ 411.97
$ 405.28
$ 419.27
$ 257.69
138.43 40,600,898,250
Alnylam Pharmaceuticals, Inc.
ALNY: NASDAQ-GS
$ 96.18 4.46 ▲ 950,123 $ 97
$ 92.17
$ 112.57
$ 47.03
NE 7,343,823,900
Pacira Pharmaceuticals, Inc.
PCRX: NASDAQ-GS
$ 92.65 3.92 ▲ 593,619 $ 92.81
$ 88.48
$ 111.997
$ 47.21
NE 3,325,393,800
Mallinckrodt plc
MNK: NYSE
$ 90.34 3.32 ▲ 1,557,875 $ 90.81
$ 87.27
$ 95.74
$ 49.08
NE 5,291,575,160
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 194.15 3.13 ▲ 810,156 $ 195.01
$ 192.3052
$ 197.64
$ 120.1401
80.9 38,405,782,250
Lannett Co Inc
LCI: NYSE
$ 48.43 2.90 ▲ 1,250,913 $ 49.07
$ 45.80
$ 59.44
$ 26.66
18.14 1,731,759,940
Celgene Corporation
CELG: NASDAQ-GS
$ 110.98 2.78 ▲ 4,115,823 $ 111
$ 108.50
$ 109.25
$ 66.85
58.1 88,729,619,800
Allergan, Inc.
AGN: NYSE
$ 211.81 2.72 ▲ 4,539,324 $ 212.87
$ 209.05
$ 214.20
$ 94.98
49.37 63,097,987,190
TESARO, Inc.
TSRO: NASDAQ-GS
$ 33.32 2.59 ▲ 470,825 $ 33.42
$ 30.80
$ 40.99
$ 22.1501
NE 1,200,952,760
Shire plc
SHPG: NASDAQ-GS
$ 212.62 2.53 ▲ 611,076 $ 213
$ 210.93
$ 264.98
$ 129.58
32.26 42,423,430,740
Medivation, Inc.
MDVN: NASDAQ-GS
$ 111.78 2.50 ▲ 1,011,232 $ 113
$ 110.09
$ 113.61
$ 54.37
79.28 8,583,474,420
Tetraphase Pharmaceuticals, Inc.
TTPH: NASDAQ-GS
$ 24.49 2.40 ▲ 2,530,397 $ 25.40
$ 23.86
$ 26.34
$ 8.01
NE 748,414,400
Vertex Pharmaceuticals Incorporated
VRTX: NASDAQ-GS
$ 113.80 2.40 ▲ 1,085,891 $ 113.96
$ 111.32
$ 118.17
$ 59.79
NE 27,093,731,600
Perrigo Company
PRGO: NYSE
$ 156.89 2.39 ▲ 876,600 $ 158.24
$ 154.56
$ 168.39
$ 125.37
131.84 21,016,356,840
Endo International plc
ENDP: NASDAQ-GS
$ 72.50 2.30 ▲ 3,098,581 $ 73.66
$ 70.19
$ 82.16
$ 53.62
NE 11,126,575,000
Sage Therapeutics, Inc.
SAGE: NASDAQ-GM
$ 39.43 2.15 ▲ 65,090 $ 39.90
$ 36.87
$ 41.01
$ 24.25
NE 1,017,017,990
BioMarin Pharmaceutical Inc.
BMRN: NASDAQ-GS
$ 87.94 2.11 ▲ 2,935,288 $ 88.37
$ 83.10
$ 88.23
$ 55.04
NE 12,937,468,980
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 96.74 1.90 ▲ 616,723 $ 97.9755
$ 94.5801
$ 99.71
$ 15.91
NE 3,333,466,920
United Therapeutics Corporation
UTHR: NASDAQ-GS
$ 131.21 1.74 ▲ 601,919 $ 132.0699
$ 129.60
$ 136.93
$ 84.63
38.59 6,202,165,490